Loading articles...

1.5M doses of AstraZeneca vaccine expected to arrive from U.S. Tuesday

Last Updated Mar 30, 2021 at 10:32 am EDT

A vial of the AstraZeneca COVID-19 vaccine is seen at a clinic in Winnipeg on March 19, 2021. THE CANADIAN PRESS/John Woods
Summary

Provinces and territories have agreed to suspend the use of the vaccine for those under 55, pending further study


They are acting on an advisory committee's concerns about a possible link between the shot and rare blood clots


The federal government is expecting around 1.5 million doses of the Oxford-AstraZeneca vaccine from the United States on Tuesday.

The vaccines are expected to arrive by truck and represent the first to come from south of the border.

Provincial governments decide on their own how to use a vaccine, but Dr. Howard Njoo, Canada’s deputy chief medical officer of health, says all provinces and territories have agreed to suspend the use of the vaccine for those under 55, pending the results of further study.

They are acting on an advisory committee’s concerns about a possible link between the shot and rare blood clots.

Dr. Heather Morrison, P.E.I.’s chief medical officer of health, says the risk of developing a serious problem after being immunized is “very, very low.”

She says people who received the AstraZeneca vaccine should look for symptoms such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, sudden onset of severe or persistent headache or blurred vision and skin bruising elsewhere than the site of vaccination, developing four to 20 days after getting the shot.